12
My Cart

Subtotal: ₹13,713.70

Note Shipping Coupon

View cartCheckout

About
Our Expertise
Our Founder
National Presence
Our Products
Highlights
Blog
Gallery
Contact Us
Home
/
/
Clarithromycin Oral Suspension 125 mg – ALCLAR 125
Clarithromycin Oral Suspension 125 mg - ALCLAR 125 - Fawn Incor
Clarithromycin Oral Suspension 125 mg - ALCLAR 125 - Image 2

Clarithromycin Oral Suspension 125 mg – ALCLAR 125

₹154.50

Clarithromycin Oral 125mg

Categories: , Tags: , , , ,

Clarithromycin Oral Suspension 125 mg – Macrolide Antibiotic for Broad-Spectrum Bacterial Infections.

ALCLAR 125: The Composition of Clarithromycin Oral 125 mg is a second-generation macrolide antibiotic that inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit. It shows high efficacy against both typical and atypical pathogens. Its excellent tissue penetration and prolonged half-life ensure sustained antibacterial activity. The oral and injectable forms allow use in a broad spectrum of outpatient and inpatient scenarios, including gastrointestinal infections when combined with PPIs and amoxicillin.

Recommended By Specialists:
✅General Physicians: It is preferred to treat the disease associated with respiratory tract infections, skin & soft tissue infections
✅Pulmonologists_ It is prefer to treat the disease associated with bronchitis, pneumonia, and atypical respiratory infections
✅Gastroenterologists –It is preferred to treat the disease associated with triple therapy for H. pylori infection

Key benefits of Clarithromycin Oral Suspension 125 mg – ALCLAR 125:
✅Broad-Spectrum Antibacterial Action – Effective against respiratory, skin, and soft tissue infections caused by Streptococcus, Staphylococcus, Mycoplasma, H. pylori, and atypical pathogens.
✅Dual Formulations for Versatile Use – Available in suspension for pediatrics, oral tablets for outpatients, and injection for severe systemic infections — ensuring complete flexibility.
✅H. pylori Eradication in GI Use – A key component in triple therapy for H. pylori eradication, improving peptic ulcer healing rates

INDICATIONS:
✅Upper & Lower Respiratory Tract Infections
✅Community-Acquired Pneumonia
✅Acute Otitis Media
✅Skin & Soft Tissue Infections
✅H. pylori Eradication (as part of triple therapy

Related Products

Follow us on

Proin volutpat vitae libero at tincidunt. Maecenas sapien lectus, vehicula vel euismod sed, vulputate

Lastudioicon-b-facebook Lastudioicon-b-twitter Lastudioicon-b-instagram Lastudioicon-b-vimeo Lastudioicon-envato
10% off when you sign up

Proin volutpat vitae libero at tincidunt. Maecenas sapien lectus, vehicula vel euismod sed, vulputate

Subscribe
Subscribe
Fawn Incor Private Limited

Fawn Incor Private Limited is one of the fastest-growing and rapidly developing PCD Pharma Franchise Company in India. With proven expertise in the healthcare sector, we cater to the diverse needs of our customers by offering a wide range of general and specialty divisions, including Gynecology, Dermatology, Orthopedics, Neurology, Ophthalmology, Cardiac-Diabetic care, and PPIs.

Facebook Instagram
USEFUL LINKS
Contact us

Panchkula (Admin Office)

Plot No 404, Basement, Industrial Area, Phase I, Panchkula (HR) 134113

Mumbai(Corporate Office)

3rd Floor, Tree House, Raghuvanshi Mills, Lower Parel (West), Mumbai – 400013 India

Netherlands (Overseas)

Fawn Inc. 217, Lichstraat, Eindhoven, Netherlands

+91-9888099264
+91 6280 986 280
+91-7814201203

info@fawnincor.com
Fawnincor@gmail.com

12
My Cart

Subtotal: ₹13,713.70

Note Shipping Coupon

View cartCheckout

Copyright © Fawn Incor Pvt. Ltd. 2024. All Rights Reserved.

×

Hello!

Click one of our contacts below to chat on WhatsApp

× How can I help you?